New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes
dc.contributor.author | Maryam Mohammadi-Khanaposhtani,Milad Nori,Yousef Valizadeh,Shahrzad Javanshir,Navid Dastyafteh,Ali Moaazam,Samanesadat Hosseini,Bagher Larijani,Hossein Adibi,Mahmood Biglar,Haleh Hamedifar,Mohammad Mahdavi,Hamdi Kamci,Ahmet Karakus,Parham Taslimi | |
dc.date.accessioned | 2023-02-10T12:28:02Z | |
dc.date.available | 2023-02-10T12:28:02Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1002/ardp.202100313 | |
dc.identifier.issn | 1521-4184 | |
dc.identifier.uri | https://dx.doi.org/10.1002/ardp.202100313 | |
dc.identifier.uri | http://hdl.handle.net/11772/9433 | |
dc.source | ARCHIV DER PHARMAZIE | |
dc.subject | Drug Discovery | |
dc.title | New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes | |
dc.type | Article | |
dc.identifier.volume | 355 | |
dc.identifier.issue | 5 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |